/

COH.AX

COCHLEAR FPO [COH]Closed

129.28−0.22 −0.17%AUD

ASX · as of Oct 14, 01:10 ET · 20m delay

Open

127.20

Prev close

129.50

Day range

126.10129.38

52-week range

88.74296.50

Volume

407.16K0.72×

Mkt cap

8.45B

P/E ttm

57.46

Fwd P/E

22.76

EPS ttm

2.25

Div yield

2.01%

Earnings

Aug 18, 2026

From 52w high

−56.40%

Price Chart

Yahoo Finance · delayed

COH.AXOct 14, 2026O 127.20H 129.38L 126.10C 129.28−0.22 (−0.17%)Vol 407.16K

SMA 50135.19
SMA 200154.07

1Y change −53.42% since Oct 13, 2025 close547 bars loadedTimes in Australia/SydneyDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

COH.AX COCHLEAR FPO [COH] · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −0.17%
1 month: −5.25%
3 months: +4.26%
6 months: −24.84%
Year to date: −50.40%
1 year: −53.60%

Valuation & ownership

Market cap: 8.45B
Enterprise value: 8.49B
P/E (ttm): 57.46
Forward P/E: 22.76
PEG ratio: 3.08
Price / book: 4.86
Price / sales (ttm): 3.60
EV / EBITDA: 17.70
EPS (ttm): 2.25
EPS (forward): 5.68
Beta (5y monthly): 0.24
Dividend yield: 2.01%
Payout ratio: 190.94%
Shares outstanding: 65.40M
Float: 65.14M
Short % of float: —
Short ratio (days): —
Held by insiders: 0.58%
Held by institutions: 60.61%
Avg volume (3m): 568.55K
50-day average: 135.04
200-day average: 153.55
52-week change: −53.60%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 41.9
vs 50-day SMA: −4.37%
vs 200-day SMA: −16.09%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 3.29%
Realised vol (20d, ann.): 41.0%
From 52-week high: −56.40%
From 52-week low: +45.68%

ANR

Analyst Consensus

16 analysts

Consensus

Hold

3.19 on a 1 (strong buy) – 5 (sell) scale

Mean target

137.09

+6.04% implied

Low 110.00Median 138.21High 165.00

Recommendation trend

Now0 / 14 / 2
1m ago / 13 /

DES

About COCHLEAR FPO [COH]

Yahoo Finance profile

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Sector: Healthcare
Industry: Medical Devices
Employees: 5,400
Headquarters: Sydney, NSW, Australia
Website: cochlear.com
Officers: Mr. Diggory William Howitt BE (Hons), MBA CEO, MD, President & Executive Director
Dr. Sarah Thom Chief Financial Officer
Mr. Jan Janssen MSc Elec Eng Chief Technology Officer
Ms. Karen O'Driscoll Chief Information Officer

SEAS

Seasonality · COH.AX

2007–2026 · monthly returns

Strongest month Aug +2.87%Weakest month Sep −1.92%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	3.2	-26.0	-15.0	-44.4	6.9	21.1	-1.5	11.7	4.2	-7.4			−50.4%
2025	10.3	-19.0	1.3	4.7	-1.1	10.7	6.0	-5.3	-7.4	2.8	-2.8	-6.6	−10.1%
2024	1.9	15.0	-3.6	-3.7	-0.8	3.0	3.9	-12.9	-6.1	0.4	7.4	-4.7	−2.9%
2023	4.1	4.6	6.5	4.2	-1.3	-5.9	4.4	13.5	-6.0	-5.7	13.4	9.4	+46.3%
2022	-10.9	15.8	1.1	2.8	-3.8	-10.9	7.8	0.0	-9.2	2.7	7.2	-4.6	−5.6%
2021	4.5	7.1	-0.2	5.5	2.0	10.8	-2.5	-4.9	-5.5	0.0	-1.2	-0.8	+14.3%
2020	7.3	-13.9	-9.7	-1.6	4.6	-2.1	0.7	1.0	3.0	7.2	3.9	-14.3	−15.9%
2019	11.4	-11.8	1.6	8.1	6.8	3.4	6.5	-1.1	-4.5	1.6	10.6	-4.0	+29.5%
2018	1.5	5.9	-1.2	6.8	1.1	2.0	1.6	6.1	-7.0	-11.5	-4.7	2.5	+1.4%
2017	2.1	4.3	3.6	3.4	4.8	6.0	-8.1	9.4	1.9	10.5	2.7	-5.3	+39.7%
2016	-1.9	9.3	-0.2	5.6	11.7	0.5	9.5	6.2	0.1	-9.2	-7.2	3.2	+28.2%
2015	6.8	8.9	0.1	-7.6	5.9	-9.5	13.9	-6.4	-2.3	6.6	6.1	1.3	+23.0%
2014	-2.9	0.1	-0.5	3.0	2.0	3.1	3.2	14.0	-4.2	5.7	-5.3	11.7	+31.9%
2013	2.1	-12.3	-3.9	-3.0	-2.2	-4.4	-1.0	-6.1	5.5	-2.6	-0.7	0.8	−25.5%
2012	-4.2	2.9	1.3	6.1	-4.5	5.0	0.2	2.2	-0.4	6.0	5.9	4.9	+27.6%
2011	-4.1	0.3	7.3	-3.0	-0.9	-9.7	-1.6	6.8	-38.7	26.3	-5.2	11.7	−22.9%
2010	-9.8	1.8	14.8	1.7	-1.8	2.1	-4.9	-2.1	1.5	1.1	10.1	2.8	+16.4%
2009	6.5	-9.3	-6.4	-0.8	9.7	5.9	-3.6	1.1	18.6	-4.0	-1.3	9.1	+24.7%
2008	-6.9	-22.7	1.5	3.7	-4.4	-19.5	1.3	24.5	7.7	-3.9	-3.0	0.2	−26.0%
2007	-2.7	0.5	14.1	-2.0	-1.9	-2.0	1.3	8.4	16.4	-12.1	10.0	-0.7	+29.1%

INSD

Insider Activity · COH.AX

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Aug 31, 2026	Freudenstein (Richard John)Director (Non-Executive)	Purchase at price 96.79 per share.	1.1K	$106.47K
Aug 23, 2026	Clarke (Caroline)Director (Non-Executive)	Purchase at price 97.23 per share.	257	$24.99K
Aug 23, 2026	Clarke (Caroline)Director (Non-Executive)	Purchase at price 96.13 per share.	444	$42.68K
Aug 23, 2026	Del Prado (Michael)Independent Non-Executive Director	Acquisition at price 69.17 per share.	412	$28.50K
Aug 19, 2026	Clarke (Caroline)Director (Non-Executive)	Purchase at price 97.10 per share.	431	$41.85K
Aug 19, 2026	Daniell (Michael Grenfell)Director (Non-Executive)	Purchase at price 96.56 per share.	386	$37.27K
Aug 19, 2026	Del Prado (Michael)Independent Non-Executive Director	Acquisition at price 67.17 per share.	76	$5.11K
Aug 18, 2026	Deans (Catriona Alison)Chairman of the Board	Purchase at price 95.60 per share.	1.4K	$133.84K
Aug 18, 2026	Mcloughlin (Christine Frances)Director (Non-Executive)	Other at price 98.66 per share.	2.4K	$236.78K
Aug 18, 2026	Mcloughlin (Christine Frances)Director (Non-Executive)	Other at price 98.66 per share.	2.4K	$236.78K
Aug 18, 2026	Penrose (Karen Lee Collett)Independent Non-Executive Director	Purchase at price 97.82 per share.	286	$27.98K
Jun 29, 2026	Janssen (Jan)Chief Technology Officer	—	2.3K	—
Feb 18, 2026	Robinson (Bruce Gregory)Director (Non-Executive)	Purchase at price 139.90 per share.	253	$35.40K
Feb 17, 2026	Penrose (Karen Lee Collett)Independent Non-Executive Director	Purchase at price 141.68 per share.	100	$14.17K
Feb 15, 2026	Freudenstein (Richard John)Director (Non-Executive)	Purchase at price 144.66 per share.	8	$1.16K
Feb 15, 2026	Freudenstein (Richard John)Director (Non-Executive)	Purchase at price 144.70 per share.	232	$33.57K
Feb 15, 2026	Freudenstein (Richard John)Director (Non-Executive)	Purchase at price 143.13 per share.	30	$4.29K
Feb 15, 2026	Freudenstein (Richard John)Director (Non-Executive)	Purchase at price 143.18 per share.	215	$30.78K
Sep 3, 2025	Howitt (Diggory William)Chief Executive Officer	Sale at price 196.49 per share.	3.1K	$609.32K
Sep 3, 2025	Howitt (Diggory William)Chief Executive Officer	Sale at price 195.46 per share.	849	$165.94K

COH.AX

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

COH.AX

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About COCHLEAR FPO [COH]

Seasonality · COH.AX

Insider Activity · COH.AX

Congress Trades · COH.AX

Investors Holding COH.AX

Investors Holding COH.AX

Congress Trades · COH.AX

Insider Activity · COH.AX

Seasonality · COH.AX

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About COCHLEAR FPO [COH]

Financial Snapshot

Earnings & Dividends

News